ALNY
Alnylam Pharmaceuticals, Inc. β’ Healthcare (#5 of 11)
$328.73
-2.14 (-0.65%)
View:
Close:$328.73
Vol:LOW(5%ile)
Ratio:0.56x
|RSI:53(Neutral)
MACD:β
β₯75%25-75%<25%
Vol.%
Sector Rotation
2026-04-01(10/10)
20d Strength (bar)
Strong (Β±4%)
Normal (-2~+3%)
5d Strength (normal: -1~+1%)
Relative Strength Trajectory
5d Strength
10d Strength
20d Strength
NASDAQ
10d early: 3~5%|20d confirm: 4~8.5%|>8.5% exhaustion
Analyst Actions
NEUTRALβ²0 UpβΌ1 Down2 Hold
Mar 25Chardan Capital
βBuy
Mar 25HC Wainwright & Co.
βBuy
Mar 16Jefferies
βΌBuy β Hold
Price Targets
(60d mean: $436, +32.5%)β²0 RaisesβΌ1 Lowers
Mar 25Chardan Capital
$425β$425New
Mar 25HC Wainwright & Co.
$510β$510New
Mar 16Jefferies
$522β$330-36.8%
Trade Setup
Entry$328.73
Target$351.04 (+6.8%)
Stop$306.42
R/R1.00
Risk-6.8%
Conv27 (LOW)
Size19 shares ($6,246)
Risk Metrics
Sharpe (20d)
0.32Poor
Volatility (20d)
36.0%Normal
Beta (60d)
0.92Average
Alpha (20d)
+4.7%Moderate+
News Analysis
EN
δΈ
ν
ζ₯
No analysis record found.